JP2022078254A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022078254A5 JP2022078254A5 JP2022036245A JP2022036245A JP2022078254A5 JP 2022078254 A5 JP2022078254 A5 JP 2022078254A5 JP 2022036245 A JP2022036245 A JP 2022036245A JP 2022036245 A JP2022036245 A JP 2022036245A JP 2022078254 A5 JP2022078254 A5 JP 2022078254A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- composition
- cmv
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 23
- 241000724252 Cucumber mosaic virus Species 0.000 claims 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims 16
- 101710132601 Capsid protein Proteins 0.000 claims 7
- 101710094648 Coat protein Proteins 0.000 claims 7
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims 7
- 101710125418 Major capsid protein Proteins 0.000 claims 7
- 101710141454 Nucleoprotein Proteins 0.000 claims 7
- 101710083689 Probable capsid protein Proteins 0.000 claims 7
- 239000000427 antigen Substances 0.000 claims 6
- 102000036639 antigens Human genes 0.000 claims 6
- 108091007433 antigens Proteins 0.000 claims 6
- 241000282465 Canis Species 0.000 claims 5
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 4
- 210000004897 n-terminal region Anatomy 0.000 claims 4
- 241000700605 Viruses Species 0.000 claims 3
- 102100021596 Interleukin-31 Human genes 0.000 claims 2
- 101710181613 Interleukin-31 Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 239000007771 core particle Substances 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 108090000565 Capsid Proteins Proteins 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16167264 | 2016-04-27 | ||
| EP16167264.7 | 2016-04-27 | ||
| PCT/EP2017/059977 WO2017186813A1 (en) | 2016-04-27 | 2017-04-26 | Treatment of canine atopic dermatitis |
| JP2019508291A JP7039561B2 (ja) | 2016-04-27 | 2017-04-26 | イヌアトピー性皮膚炎の治療 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508291A Division JP7039561B2 (ja) | 2016-04-27 | 2017-04-26 | イヌアトピー性皮膚炎の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022078254A JP2022078254A (ja) | 2022-05-24 |
| JP2022078254A5 true JP2022078254A5 (enExample) | 2022-11-07 |
| JP7273214B2 JP7273214B2 (ja) | 2023-05-12 |
Family
ID=56024099
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508291A Active JP7039561B2 (ja) | 2016-04-27 | 2017-04-26 | イヌアトピー性皮膚炎の治療 |
| JP2022036245A Active JP7273214B2 (ja) | 2016-04-27 | 2022-03-09 | イヌアトピー性皮膚炎の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019508291A Active JP7039561B2 (ja) | 2016-04-27 | 2017-04-26 | イヌアトピー性皮膚炎の治療 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10946078B2 (enExample) |
| EP (1) | EP3448422A1 (enExample) |
| JP (2) | JP7039561B2 (enExample) |
| KR (2) | KR102469478B1 (enExample) |
| CN (2) | CN116688110A (enExample) |
| AR (1) | AR108333A1 (enExample) |
| AU (1) | AU2017256727B2 (enExample) |
| BR (1) | BR112018071965A2 (enExample) |
| CA (1) | CA3019653A1 (enExample) |
| CL (1) | CL2018002960A1 (enExample) |
| CO (1) | CO2018011087A2 (enExample) |
| EA (1) | EA201892003A1 (enExample) |
| MX (2) | MX394254B (enExample) |
| NZ (2) | NZ747512A (enExample) |
| UA (1) | UA126852C2 (enExample) |
| WO (1) | WO2017186813A1 (enExample) |
| ZA (1) | ZA201806503B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI741241B (zh) * | 2017-12-11 | 2021-10-01 | 美商聯合生物醫學公司 | 用於治療及/或預防異位性皮膚炎之il-31胜肽免疫原及其劑型 |
| MX2020009642A (es) | 2018-03-16 | 2021-01-08 | Zoetis Services Llc | Anticuerpos monoclonales de interleucina-31 para uso veterinario. |
| MX2020009639A (es) | 2018-03-16 | 2021-01-08 | Zoetis Services Llc | Vacunas de peptídos contra interleucina-31. |
| EP3897711A1 (en) * | 2018-12-20 | 2021-10-27 | Saiba AG | Virus-like particles of cmv modified by fusion |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040024004A1 (en) | 2001-05-04 | 2004-02-05 | Sherman Barry M. | Novel compositions and methods for enhancing potency or reducing adverse side effects of opioid agonists |
| EP2196217A1 (en) | 2001-09-14 | 2010-06-16 | Cytos Biotechnology AG | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| MX2007003171A (es) | 2004-09-21 | 2007-05-23 | Cytos Biotechnology Ag | Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico. |
| CN101023103A (zh) * | 2004-09-21 | 2007-08-22 | 赛托斯生物技术公司 | 包含ap205外壳蛋白和抗原性多肽的融合蛋白的病毒样颗粒 |
| AU2006214404B2 (en) | 2005-02-14 | 2012-03-08 | Bristol-Myers Squibb Company | Methods of treating skin disorders using an IL-31RA antagonist |
| JP5484732B2 (ja) | 2005-12-14 | 2014-05-07 | サイトス バイオテクノロジー アーゲー | 過敏症の治療のための免疫賦活性核酸パッケージ粒子 |
| WO2008112674A1 (en) | 2007-03-12 | 2008-09-18 | Irm Llc | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| US8465756B2 (en) * | 2009-08-12 | 2013-06-18 | National Health Research Institutes | Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapy |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| EP2941646A1 (en) | 2013-01-04 | 2015-11-11 | Bristol-Myers Squibb Company | Positive allosteric modulators and silent allosteric modulators of the opioid receptor |
| WO2015042596A1 (en) | 2013-09-23 | 2015-03-26 | Kindred Biosciences, Inc | Treatment of atopic dermatitis in non-human animals |
| MA40824A (fr) * | 2014-10-22 | 2017-08-29 | Saiba Gmbh | Particules de cmv de type virus modifié |
-
2017
- 2017-04-26 KR KR1020187031190A patent/KR102469478B1/ko active Active
- 2017-04-26 US US16/097,156 patent/US10946078B2/en active Active
- 2017-04-26 EA EA201892003A patent/EA201892003A1/ru unknown
- 2017-04-26 AU AU2017256727A patent/AU2017256727B2/en active Active
- 2017-04-26 MX MX2018012973A patent/MX394254B/es unknown
- 2017-04-26 CA CA3019653A patent/CA3019653A1/en active Pending
- 2017-04-26 BR BR112018071965A patent/BR112018071965A2/pt unknown
- 2017-04-26 WO PCT/EP2017/059977 patent/WO2017186813A1/en not_active Ceased
- 2017-04-26 NZ NZ747512A patent/NZ747512A/en unknown
- 2017-04-26 JP JP2019508291A patent/JP7039561B2/ja active Active
- 2017-04-26 AR ARP170101065A patent/AR108333A1/es unknown
- 2017-04-26 EP EP17723294.9A patent/EP3448422A1/en active Pending
- 2017-04-26 CN CN202310179224.2A patent/CN116688110A/zh active Pending
- 2017-04-26 NZ NZ787511A patent/NZ787511A/en unknown
- 2017-04-26 UA UAA201809978A patent/UA126852C2/uk unknown
- 2017-04-26 CN CN201780025651.8A patent/CN109562156B/zh active Active
- 2017-04-26 KR KR1020227040222A patent/KR20220162800A/ko not_active Ceased
-
2018
- 2018-10-01 ZA ZA2018/06503A patent/ZA201806503B/en unknown
- 2018-10-16 CO CONC2018/0011087A patent/CO2018011087A2/es unknown
- 2018-10-17 CL CL2018002960A patent/CL2018002960A1/es unknown
- 2018-10-24 MX MX2022009171A patent/MX2022009171A/es unknown
-
2022
- 2022-03-09 JP JP2022036245A patent/JP7273214B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022078254A5 (enExample) | ||
| JP2021182922A5 (enExample) | ||
| JP2022160401A5 (enExample) | ||
| JP2018536433A5 (enExample) | ||
| JP3681753B2 (ja) | 異種ペプチドのベクターとしての改質植物ウイルス | |
| JP2873880B2 (ja) | ポックスウイルス成分の組み合わせにもとづく類属免疫誘導剤、その製造方法 | |
| JP6942309B2 (ja) | フラビウイルスウイルス様粒子 | |
| JP2017503482A5 (enExample) | ||
| JP2007211026A (ja) | パピロマウイルス偽ウイルス及びその調製方法 | |
| Shoja et al. | Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials | |
| JPH08308575A (ja) | 組換アデノウイルス | |
| Pumpens et al. | Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes | |
| JP2020125323A5 (enExample) | ||
| JP2019500320A5 (enExample) | ||
| CN116139264A (zh) | 重组火鸡疱疹病毒活载体疫苗及其应用 | |
| CN106480070B (zh) | 一种用于展示目的多肽的多肽载体及其用途 | |
| JP2019506168A5 (enExample) | ||
| JP5713533B2 (ja) | 伝染性ファブリキウス嚢病ウイルス（ｉｂｄｖ）に由来する中空キメラ性ウイルス様粒子、これらの製造および応用 | |
| JP2007504112A5 (enExample) | ||
| WO2022037095A1 (zh) | 优化的表达新型冠状病毒抗原的核苷酸序列及其应用 | |
| JP6675185B2 (ja) | 免疫誘導剤およびその製造方法 | |
| CN1373771A (zh) | 疫苗 | |
| CN119144656A (zh) | 汉坦病毒抗原组合物 | |
| CN106421774A (zh) | PreS1用于制备乙肝疫苗以及治疗慢性乙型肝炎的用途 | |
| JP2012501351A5 (enExample) |